Semaglutide

• Can GLP-1s lower some cancer risks? What new research suggests

  Currently, two generic versions of Ozempic and Wegovy are available for Canadians to purchase for patients who use it to treat diabetes or weight loss for a fraction of the cost.

  Health

  Jun 11
  
• Generic semaglutide to hit Canadian pharmacies this week at lower cost

  Health Canada approved both Dr. Reddy's and Apotex's generic semaglutide — the active ingredient in brand-name Ozempic and Wegovy — about three weeks ago.

  Health

  May 20
  
• Advertisement
• Canada approves 2nd generic version of semaglutide

  Canada is the first G7 country to authorize generic semaglutide. There are now seven other submissions currently under review for generic semaglutide by different companies.

  Health

  May 1
• Advertisement
• With Canada approving 1st generic semaglutide, how will costs compare?

  Manufactured by Dr. Reddy’s Laboratories in India, the injectable medication has been approved for once-a-week treatment of Type 2 diabetes in adults.

  Health

  Apr 29
• Could GLP-1 drugs help your mental health? New study finds a link

  Semaglutide, the active ingredient in GLP-1 drugs, was associated with a lower risk of worsening mental health, a study published in Lancet Psychiatry found.

  Health

  Mar 20
• Novo Nordisk says generic Ozempic, Wegovy will slow sales in Canada

  Novo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result in more generics and hurt sales.

  Health

  Feb 4
• Health Canada warns of fake semaglutide drugs, cites ‘product safety’ risks

  Health Canada is warning Canadians of the dangers of buying "fake or unauthorized products" meant to replicate popular GLP-1 drugs such as Ozempic, Rybelsus and Wegovy.

  Consumer

  Jan 22
• Health Canada issues recall notice for compounded semaglutide drugs

  Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy.

  Health

  Jan 22, 2025
• Advertisement
• Wegovy approved in Canada to combat risk of non fatal-heart attack

  Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults.

  Health

  Nov 27, 2024
• Advertisement
• Can semaglutide help reduce opioid overdoses? What new study suggests

  Semaglutide – a key ingredient in Ozempic and Wegovy – was associated with a lower risk of opioid overdose in patients with Type 2 diabetes and opioid use disorder, research shows.

  Health

  Sep 26, 2024